These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37105899)

  • 1. Eosinopenia is associated with adverse outcomes after COVID-19 infection: A perspective from Japan.
    Ito A; Ishida T; Nakanishi Y; Kobe H; Tokioka F
    Respirology; 2023 Jul; 28(7):677-680. PubMed ID: 37105899
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
    Soni M
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.
    Cazzaniga M; Fumagalli LAM; D'angelo L; Cerino M; Bonfanti G; Fumagalli RM; Schiavo G; Lorini C; Lainu E; Terragni S; Chiarelli M; Scarazzati C; Bonato C; Zago M
    Int J Clin Pract; 2021 Jul; 75(7):e14047. PubMed ID: 33497517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.
    Valverde-Monge M; Cañas JA; Barroso B; Betancor D; Ortega-Martin L; Gómez-López A; Rodríguez-Nieto MJ; Mahíllo-Fernández I; Sastre J; Del Pozo V
    Front Immunol; 2021; 12():668074. PubMed ID: 34149705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID-19 infection.
    Krishnamurthy V; Sujatha KJ; Kumar TA; Phaniraj P; Shankar T; Raj MP
    Ann Afr Med; 2022; 21(3):278-282. PubMed ID: 36204916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinopenia as a Predictive Factor of the Short-Term Risk of Mortality and Infection after Acute Cerebral Infarction.
    Hori YS; Kodera S; Sato Y; Shiojiri T
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1307-12. PubMed ID: 26971036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
    Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Original article: Soni M. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection. Int J Lab Hematol. 2020;00:1-5. https://doi.org/10.1111/ijlh.13425.
    van Duijnhoven HLP; Leuvenink J; Keuren JFW
    Int J Lab Hematol; 2021 Dec; 43(6):e287-e289. PubMed ID: 33973723
    [No Abstract]   [Full Text] [Related]  

  • 9. Original Article: Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
    Soni M
    Int J Lab Hematol; 2021 Dec; 43(6):e303. PubMed ID: 33973726
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic usefulness of eosinopenia in the pediatric intensive care unit.
    Kim YH; Park HB; Kim MJ; Kim HS; Lee HS; Han YK; Kim KW; Sohn MH; Kim KE
    J Korean Med Sci; 2013 Jan; 28(1):114-9. PubMed ID: 23341721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil count (EC) as a diagnostic and prognostic marker for infection in the internal medicine department setting.
    Karakonstantis S; Gryllou N; Papazoglou G; Lydakis C
    Rom J Intern Med; 2019 Jun; 57(2):166-174. PubMed ID: 30517081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID 19 infection.
    P P; Krishnamurthy V; Kumar TA
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
    Perlini S; Ciprandi G; Castagnoli R; Licari A; Marseglia GL
    Allergy Asthma Proc; 2020 Nov; 41(6):e80-e82. PubMed ID: 33109314
    [No Abstract]   [Full Text] [Related]  

  • 14. Eosinopenia in COVID-19: What we missed so far?
    Davido B; Partouche B; Jaffal K; de Truchis P; Herr M; Pepin M
    J Microbiol Immunol Infect; 2021 Oct; 54(5):1006-1007. PubMed ID: 33648873
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
    Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
    J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinopenia as a predictor of unexpected re-admission and mortality after intensive care unit discharge.
    Yip B; Ho KM
    Anaesth Intensive Care; 2013 Mar; 41(2):231-41. PubMed ID: 23530790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive role of blood eosinophils in adult varicella patients.
    Yang L; Zhang W; Shen X; Chang J; Liu M
    Epidemiol Infect; 2022 Jun; 150():e127. PubMed ID: 35726529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study.
    Eijmael M; Janssens N; le Cessie S; van Dooren Y; Koster T; Karim F
    Infection; 2021 Dec; 49(6):1325-1329. PubMed ID: 34625911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD.
    Echevarria C; Steer J; Prasad A; Quint JK; Bourke SC
    Thorax; 2023 Nov; 78(11):1090-1096. PubMed ID: 37487711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EOSINOPENIA: an early, effective and relevant COVID-19 biomarker?
    Roca E; Ventura L; Zattra CM; Lombardi C
    QJM; 2021 Feb; 114(1):68-69. PubMed ID: 32877511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.